274 related articles for article (PubMed ID: 34272737)
1. Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements.
Nash E; Sabih AH; Chetwood J; Wood G; Pandya K; Yip T; Majumdar A; McCaughan GW; Strasser SI; Liu K
Med J Aust; 2021 Sep; 215(6):261-268. PubMed ID: 34272737
[TBL] [Abstract][Full Text] [Related]
2. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
[TBL] [Abstract][Full Text] [Related]
4. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.
Sobhonslidsuk A; Poovorawan K; Soonthornworasiri N; Pan-Ngum W; Phaosawasdi K
BMC Gastroenterol; 2016 Oct; 16(1):135. PubMed ID: 27793116
[TBL] [Abstract][Full Text] [Related]
5. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
6. The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.
Vega M; Verma M; Beswick D; Bey S; Hossack J; Merriman N; Shah A; Navarro V;
Drug Saf; 2017 Sep; 40(9):783-787. PubMed ID: 28555362
[TBL] [Abstract][Full Text] [Related]
7. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced liver injury.
Katarey D; Verma S
Clin Med (Lond); 2016 Dec; 16(Suppl 6):s104-s109. PubMed ID: 27956449
[TBL] [Abstract][Full Text] [Related]
9. Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements.
Kesar V; Channen L; Masood U; Grewal P; Ahmad J; Roth NC; Odin JA
Liver Transpl; 2022 Feb; 28(2):188-199. PubMed ID: 34370392
[TBL] [Abstract][Full Text] [Related]
10. An update on drug induced liver injury.
Rangnekar AS; Fontana RJ
Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol.
Chughlay MF; Kramer N; Werfalli M; Spearman W; Engel ME; Cohen K
Syst Rev; 2015 Jun; 4():84. PubMed ID: 26066646
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia.
Nash E; Nicoll A; Batt N; George J; Perananthan V; Prince D; Wallace M; Gow P; Vaz K; Chitturi S; Flores JE; Braund A; Bonnichsen M; Riordan S; Humphris J; Duong T; McKenzie C; Liu K; Strasser SI
Aliment Pharmacol Ther; 2024 Apr; 59(8):953-961. PubMed ID: 38372012
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil.
Santos G; Figueira ERR; D'Albuquerque LAC; Lisboa PB; de Almeida MD; Filgueira NA; Boin I; Porta G; da Silva RCMA; Viana CFG; Faria LC; Alvares-da-Silva MR; de Moraes ACP; Morsoletto DBG; Codes L; Paraná R
Ann Hepatol; 2021; 23():100310. PubMed ID: 33508520
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
15. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
16. A prospective nationwide study of drug-induced liver injury in Korea.
Suk KT; Kim DJ; Kim CH; Park SH; Yoon JH; Kim YS; Baik GH; Kim JB; Kweon YO; Kim BI; Kim SH; Kim IH; Kim JH; Nam SW; Paik YH; Suh JI; Sohn JH; Ahn BM; Um SH; Lee HJ; Cho M; Jang MK; Choi SK; Hwang SG; Sung HT; Choi JY; Han KH
Am J Gastroenterol; 2012 Sep; 107(9):1380-7. PubMed ID: 22733303
[TBL] [Abstract][Full Text] [Related]
17. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose.
Craig DG; Reid TW; Wright EC; Martin KG; Davidson JS; Hayes PC; Simpson KJ
Aliment Pharmacol Ther; 2012 Mar; 35(6):705-13. PubMed ID: 22260637
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.
Chughlay MF; Kramer N; Spearman CW; Werfalli M; Cohen K
Br J Clin Pharmacol; 2016 Jun; 81(6):1021-9. PubMed ID: 26757427
[TBL] [Abstract][Full Text] [Related]
19. Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network.
Bessone F; García-Cortés M; Medina-Caliz I; Hernandez N; Parana R; Mendizabal M; Schinoni MI; Ridruejo E; Nunes V; Peralta M; Santos G; Anders M; Chiodi D; Tagle M; Montes P; Carrera E; Arrese M; Lizarzabal MI; Alvarez-Alvarez I; Caballano-Infantes E; Niu H; Pinazo J; Cabello MR; Lucena MI; Andrade RJ
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e548-e563. PubMed ID: 33434654
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes among patients admitted to hospital with antiretroviral and/or antituberculosis drug-induced liver injury.
Mehta R; Ive P; Evans D; Menezes CN
S Afr Med J; 2021 Apr; 111(5):474-481. PubMed ID: 34852891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
